Dashyant Dhanak Deciphera Pharmaceuticals, Inc. (DCPH) insider trading activity

DCPH Quotes by TradingView

Dashyant Dhanak is EVP & Chief Scientific Officer of Deciphera Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of DCPH, which is worth approximately $0. The most recent transaction as insider was on Jun 11, 2024, when has been sold 184,088 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Dashyant Dhanak Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 11 2024
SELL
Sale (or disposition) back to the issuer
-
184,088 Reduced 100.0%
0 Common Stock
Jun 11 2024
BUY
Grant, award, or other acquisition
-
25,913 Added 12.34%
184,088 Common Stock
Feb 15 2024
BUY
Grant, award, or other acquisition
-
17,275 Added 9.85%
158,175 Common Stock
Sep 15 2023
BUY
Grant, award, or other acquisition
-
140,900 Added 50.0%
140,900 Common Stock

Also insider at

INCY
INCYTE CORP Healthcare
EVP & Chief Scientific Officer
DD

Dashyant Dhanak

EVP & Chief Scientific Officer
Wilmington, DE

Track Institutional and Insider Activities on DCPH

Follow Deciphera Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DCPH shares.

Notify only if

Insider Trading

Get notified when an Deciphera Pharmaceuticals, Inc. insider buys or sells DCPH shares.

Notify only if

News

Receive news related to Deciphera Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DCPH